BiopharmaTrend.com

Resonant Therapeutics

Resonant Therapeutics

Private company
RESONANT THERAPEUTICS

Developer of novel therapeutics designed to treat cancer. The Company's proprietary platform focuses on the tumor microenvironment and data science to identify novel tumor-selective targets and anti-tumor antibodies with unprecedented speed.


Founded
2016
Status
Private company
Geography
United States of America based
Funding
$1.960 M
Research papers
1

Products

IMPaCT

Introducing IMPaCT (Integrated Microenvironment Pathway Catalog and Triage)—Resonant Therapeutic's proprietary discovery platform.

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page